A study released Friday found that kid-size doses of Pfizer’s Covid vaccine are nearly 91 percent effective at preventing symptomatic infections in 5- to 11-year-olds.
Related Articles
-
Incurable Nipah brain virus kills teenager in India
Authorities in southern India’s Kerala state are taking preventive steps after the death of a 14-year-old boy from the Nipah virus and...
-
Dodgers star Mookie Betts breaks left hand and it’s not clear when the MVP candidate will return
LOS ANGELES — Dodgers shortstop Mookie Betts broke his left hand when he was hit by a pitch during the...
-
South African scientists detect new virus variant amid spike
JOHANNESBURG — A new coronavirus variant has been detected in South Africa that scientists say is a concern because...
-
FDA authorizes Pfizer vaccine for children 12 to 15
The Food and Drug Administration on Monday lowered the age that people can receive Pfizer’s Covid-19 vaccine in the...
-
As omicron lurks, Native Americans wary of boosters
When Covid-19 vaccines first became available, Native Americans acted swiftly and with determination to get their shots — as...
-
Asian have 88% higher exposure to cancer-linked ‘forever chemicals’ than whites in U.S.
New research reveals that Asian Americans have significantly greater exposure to cancer-linked “forever chemicals” compared to other races. The...
-
Overdose deaths decreased for first time in 5 years, but still topped 100,000
Drug overdose deaths decreased slightly last year, falling for the first time since 2018, early data from the Centers...
-
CDC strengthens RSV vaccine recommendation only for the oldest adults
U.S. health officials on Wednesday made a stronger endorsement for RSV vaccinations for people 75 and older, but offered...
Recent Comments